Homozygous familial hypercholesterolemia c2271delT by mutation of the LDL receptor gene, detected only in Mexican;Hipercolesterolemia familiar homocigota por la mutación c2271delT del gen del receptor LDL, detectada únicamente en Mexicanos

Gaceta Medica de Mexico

Volumn 147, Issue 5, 2011, Pages 394-398

  Martínez, Lizbeth ^a   Sánchez, María Luisa Ordóñez ^b   Letona, Rosario ^b   Sumano, Verónica Olvera ^a   Guerra, Mariano Miguel ^a   Tusié Luna, María Teresa ^b   Aguilar Salinas, Carlos Alberto ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Familial hypercholesterolemia; Genetically isolated populations; Homozygous familial hypercholesterolemia; LDL receptor; Mexico

Indexed keywords

EZETIMIBE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; DRUG MEGADOSE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; HOMOZYGOSITY; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; MEXICO; TREATMENT RESPONSE; XANTHOMA;

ADOLESCENT; FEMALE; HOMOZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; MEXICO; MUTATION; PEDIGREE; RECEPTORS, LDL;

EID: 83655192548     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Aguilar Salinas CA. Hipercolesterolemia familiar. Rev Invest Clin. 2001;53(3):254-65.
2. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence, review. Am J Epidemiol. 2004;160(5):407-20.
3. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis. 1994;111(2):175-82.
4. British Heart Foundation. [Internet] Disponible en: www.ucl.ac.uk/ldlr/Current/. Acceso: 1 de agosto de 2011.
5. Soutar AK, Naoumova RP. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nature clinical practice. 2007;4(4): 214-25.
6. Robles Osorio L, Huerta Zepeda A, Ordoñez ML, et al. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico. Arch Med Res. 2006;37(1):102-8.
7. Vaca G, Vázquez A, Magaña MT, et al. Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia. Atherosclerosis. 2011;218(2):391-6.
8. Enciclopedia de los Municipios de México, estado de Oaxaca. [Internet] Disponible en: http://www.inafed.gob.mx/work/templates/enciclo/oaxaca/municipios/20073a.htm. Revisado el 1 de agosto de 2011.
9. Yamamoto T, Davis CG, Brown MS, et al. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 1984;39(1):27-38.
10. Medeiros AM, Alves AC, Francisco V, Bourbon M. On behalf of the investigators of the Portuguese FH Study Update of the Portuguese Familial Hypercholesterolemia Study. Atherosclerosis. 2010;212(2):553-8.
11. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis. 2003;168(1):1-14.
12. Humphries SE, Whittall RA, Hubbart CS, et al Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet. 2006;43(12): 943-9.
13. Li SG. Familial hypercholesterolemia. N Engl J Med. 2009;360 (18):1885.
14. Rajput R, Bhansali A. Tumorous xanthomas in a young male with familial hypercholesterolaemia. Arch Dis Child. 2006;91(10):827.
15. Aggarwal A, Gupta A, Narang M, Faridi MM. Familial Hypercholesterolemia with coarctation of aorta. J Postgrad Med. 2007;53(3):185-6.
16. Al-Allaf A, Coutelle C, Waddington S, David AL, Harbottle R, Themis M. LDLR-gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesInternational. Archives of Medicine. 2010;3:36.
17. Fahed AC, Nemer G. Familial hypercholesterolemia: the lipids or the genes? Nutrition & Metabolism. 2011;8:23.